Olanzapine treatment of eight adolescent patients with psychosis

Human Psychopharmacology

Volumn 19, Issue 1, 2004, Pages 53-56

  Ercan, Eyup Sabri ^a   Kutlu, Ayşe ^a   Varan, Azmi ^a   Çikoǧlu, Sibel ^a   Coşkunol, Hakan ^a   Bayraktar, Erhan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Adolescent; Neuroleptic drug treatment; Olanzapine

Indexed keywords

ALPRAZOLAM; ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; DIAZEPAM; FLUOXETINE; HALOPERIDOL; LITHIUM; OLANZAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHOOL CHILD; SEDATION; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHILD; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0742307187     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.547     Document Type: Article

References (17)

1. Bhadrinath BR. 1998. Olanzapine in Tourette syndrome. Br J Psychiatry 172: 366.
2. Dabkowska M. 2002. An open label study of olanzapine in the first episode of schizophrenia in adolescents. Eur Psychiatry 17: 115.
3. Dittmann RW, Junghan J. 1999. Olanzapine treatment of psychotic adolescents - change of body weight and adverse event profile. Neuropsychopharmacology 9: 269-270.
4. Gothelf D, Falk B, Singer B, et al. 2002. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 159: 1055-1057.
5. Grothe DR, Calis KA, Jacobsen L, et al. 2000. Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia. J Clin Psychopharmacol 20: 220-225.
6. Haapasalo-Pesu KM, Saarijarvi S. 2001. Olanzapine induces remarkable weight gain in adolescent patients. Eur Child Adolesc Psychiatry 10: 205-208.
7. Horrigan JP, Barnhill LJ, Courvoisie HE. 1997. Olanzapine in PDD. J Am Acad Child Adolesc Psychiatry 36: 1166-1167.
8. Krishnamoorthy J, King BH. 1998. Open-label olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol 2: 107-113.
9. Kumra S, Jacobsen KL, Lenane MS, et al. 1998. Childhood-onset schizophrenia: an open label study of olanzapine in adolescents. J Am Acad Child Adolesc Psychiatry 37: 377-385.
10. La Via MC, Gray N, Kaye WH. 2000. Case reports of olanzapine treatment of anorexia nervosa. Int J Eat Disord 27: 363-366.
11. Malek-Ahmadi P, Simonds JF. 1998. Olanzapine for autistic disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 37: 902.
12. Malone RP, Cater J, Sheikh RM, Choudhury MS, Delaney MA. 2001. Olanzapine versus Haloperidol in children with autistic disorder: an open pilot study. J Am Acad Child Adolesc Psychiatry 40: 887-894.
13. Mandoki M. 1997. Olanzapine in the treatment of early-onset schizophrenia in children and adolescents. Biol Psychiatry 41: 22.
14. Mehler C, Wewetzer Ch, Schulze U, Warnke A, Theisen F, Dittmann RW. 2001. Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases. Eur Child Adolesc Psychiatry 10: 151-157.
15. Potenza MN, Holmes JP, Kanes SJ, McDougle CJ. 1999. Olanzapine treatment of children, adolescent, and adults with pervasive developmental disorders: an open label pilot study. J Clin Psychopharmacol 19: 37-44.
16. Remschmidt H, Hennighausen K, Clement HW, Heiser P, Schulz E. 2000. Atypical neuroleptics in child and adolescent psychiatry. Eur Child Adolesc Psychiatry 9: 9-19.
17. Toren P, Laor N, Weizman A. 1998. Use of atypical neuroleptics in child and adolescent psychiatry. J Clin Psychiatry 59: 644-656.